{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:13:34Z","timestamp":1761974014204,"version":"build-2065373602"},"reference-count":9,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.jaip.2015.05.020","type":"journal-article","created":{"date-parts":[[2015,6,25]],"date-time":"2015-06-25T06:18:17Z","timestamp":1435213097000},"page":"817-818","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Treatment of adult hyper-IgD syndrome with canakinumab"],"prefix":"10.1016","volume":"3","author":[{"given":"Casey D.","family":"Curtis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charity C.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2015.05.020_bib1","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1365-2141.2008.07036.x","article-title":"Dysregulation of innate immunity: hereditary periodic fever syndromes","volume":"144","author":"Bodar","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jaip.2015.05.020_bib2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1651-2227.2010.01974.x","article-title":"Hyperimmunoglobulinemia D and periodic fever syndrome in children: review on therapy with biological drugs and case report","volume":"100","author":"Korppi","year":"2011","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.jaip.2015.05.020_bib3","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1093\/rheumatology\/kem200","article-title":"Diagnostic value of serum immunoglobulinaemia D level in patients with a clinical suspicion of hyper IgD syndrome","volume":"46","author":"Ammouri","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaip.2015.05.020_bib4","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1542\/peds.2010-3639","article-title":"SOFREMIP (Soci\u00e9t\u00e9 Francophone pour la Rhumatologie et les Maladies Inflammatoires en P\u00e9diatrie); CRI (Club Rhumatismes et Inflammations). Mevalonate kinase deficiency: a survey of 50 patients","volume":"128","author":"Bader-Meunier","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaip.2015.05.020_bib5","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.autrev.2012.07.027","article-title":"Biologic drugs in autoinflammatory syndromes","volume":"12","author":"Caorsi","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaip.2015.05.020_bib6","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1093\/rheumatology\/kes097","article-title":"Efficacy of interleukin-1-targeting drugs in mevalonate kinase deficiency","volume":"51","author":"Galeotti","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaip.2015.05.020_bib7","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1365-2249.2011.04533.x","article-title":"Immunology in clinic review series: focus on autoinflammatory diseases: update on monogenic autoinflammatory diseases: the role of interleukin (IL)-1 and an emerging role for cytokines beyond IL-1","volume":"167","author":"Golbach-Mansky","year":"2011","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaip.2015.05.020_bib8","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1136\/ard.2011.152728","article-title":"Two-year results from an open-label, multicentre, phase III study evaluating the safety and efficacy of canakinumab in patients with cryopyrin-associated periodic syndrome across different severity phenotypes","volume":"70","author":"Kuemmerle-Deschner","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaip.2015.05.020_bib9","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1056\/NEJMoa0810787","article-title":"Use of canakinumab in the cryopyrin-associated periodic syndrome","volume":"360","author":"Lachmann","year":"2009","journal-title":"N\u00a0Engl J Med"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219815002652?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219815002652?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:08:08Z","timestamp":1761973688000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219815002652"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":9,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S2213219815002652"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2015.05.020","relation":{},"ISSN":["2213-2198"],"issn-type":[{"type":"print","value":"2213-2198"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of adult hyper-IgD syndrome with canakinumab","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2015.05.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}